Search

Your search keyword '"Carfilzomib -- Forecasts and trends"' showing total 4 results
Start Over Descriptor "Carfilzomib -- Forecasts and trends"
4 results on '"Carfilzomib -- Forecasts and trends"'

1. AMGEN HIGHLIGHTS HEMATOLOGY PORTFOLIO AT ASH 2023

Subjects
Horizon Therapeutics PLC -- Forecasts and trends, Oncology, Experimental -- Forecasts and trends, Governmental investigations -- Forecasts and trends, B cells -- Forecasts and trends, Cancer -- Care and treatment -- Research, Carfilzomib -- Forecasts and trends, Market trend/market analysis, Business, News, opinion and commentary
Abstract

Multiple Investigator Sponsored Studies Support the Potential of BLINCYTO(blinatumomab) Across Acute Lymphoblastic Leukemia Treatment Paradigm New Data Reinforce KYPROLIS(carfilzomib) as an Important Treatment Option for Relapsed or Refractory Multiple Myeloma [...]

Published
2023

2. DelveInsight Evaluates a Robust Waldenstrom's Macroglobulinemia Pipeline as 20+ Influential Pharma Players to Set Foot in the Domain

Subjects
Bristol-Myers Squibb Co. -- Forecasts and trends, Carfilzomib -- Forecasts and trends, Industrial research -- United States, Pharmaceutical industry -- Forecasts and trends, Research and development, Market trend/market analysis, Banking, finance and accounting industries, Business
Abstract

New York, USA, April 24, 2023 (GLOBE NEWSWIRE) -- DelveInsight Evaluates a Robust Waldenstrom's Macroglobulinemia Pipeline as 20+ Influential Pharma Players to Set Foot in the Domain The prevalence of [...]

Published
2023

3. Rising Acute Leukemia Cases In The Geriatric Population Is Driving The Acute Myeloid Leukemia Market As Per The Business Research Company's Acute Myeloid Leukemia Global Market Report 2022

Subjects
Oncology, Experimental -- Forecasts and trends, Business information services -- Forecasts and trends, Business -- Research, Nilotinib -- Forecasts and trends, Carfilzomib -- Forecasts and trends, Cancer -- Research, Business database, Market trend/market analysis, Banking, finance and accounting industries, Business
Abstract

LONDON, June 08, Jun 08, 2022 (GLOBE NEWSWIRE via COMTEX) -- EQNX::TICKER_START EQNX::TICKER_END According to The Business Research Company's research report on the acute myeloid leukemia market, the increase in [...]

Published
2022

4. Metastatic Cancer Drug Market Size Worth $68.34Bn, Globally, by 2028 at 4.2% CAGR - Exclusive Report by The Insight Partners

Subjects
United States. Food and Drug Administration, Insight Partners -- Forecasts and trends, Oncology, Experimental -- Forecasts and trends, Prostate cancer -- Drug therapy, Generic drugs -- Forecasts and trends, Metastasis -- Drug therapy, Nilotinib -- Forecasts and trends, Carfilzomib -- Forecasts and trends, Liver cancer -- Drug therapy, Venture capital companies -- Forecasts and trends, Cancer -- Research, Pancreatic cancer -- Drug therapy, Market trend/market analysis, Banking, finance and accounting industries, Business
Abstract

New York, April 13, Apr 13, 2022 (GLOBE NEWSWIRE via COMTEX) -- The Insight Partners published latest research study on 'Metastatic Cancer Drug Market Forecast to 2028 - COVID-19 Impact [...]

Published
2022

Catalog

Books, media, physical & digital resources
See catalog results